AIM: To study the role of androgen receptor (AR) in hormone-dependent and hormone-independent prostate cancer cell proliferation by knocking down AR expression with adenovirus-delivered siRNA.
目的：利用RNA干涉技术抑制雄激素受体（AR）的表达，研究AR在激素依赖性和激素非依赖性前列腺癌细胞增殖中的作用。
To develop an androgen receptor (AR) reporter gene assay in which the reporter gene is chloramphenicol acetyltransferase (CAT).
建立以氯霉素乙酰化酶(CAT)为报告基因的雄激素受体(AR)报告基因试验。
Objective to determine the gene regulation of androgen receptor (AR).
目的：研究雄激素受体(AR)的基因调控。
Conclusions Androgen receptor gene CAG length showed polymorphism in older men, most of the CAG length focused on 21-24. This study offered the basic data on relationship for AR gene and disease.
结论自然人群中老年男性雄激素受体基因CAG重复序列呈现多态性，多数集中在21 - 24，为进一步研究AR基因变异与疾病的关系提供依据。
To study the clinical features and the role of androgen receptor (ar) and insulin receptor (IR) in auto-para endocrine control of asymmetric polycystic ovaries (PCO).
探讨不对称性多囊卵巢(PCO)的临床特点及雄激素受体(AR)和胰岛素受体(IR)在其发病机制中的作用。
Objective:To investigate the relationship between the polymorphic CAG short-tandem repeat(STR) at the androgen receptor(AR) gene exon 1 and lung cancer.
目的：探讨人雄激素受体（AR）基因第一外显子CAG串联短重复序列（STR）多态性与肺癌发生之间的关系。
Objective: to probe the role of androgen receptor (ar) and insulin receptor (INSR) in pathogenesis of asymmetric polycystic ovaries (PCO) as local factors.
目的：探讨雄激素受体(AR)和胰岛素受体(INSR)在不对称性多囊卵巢(PCO)局部发病机制中的作用。
Compounds of structural formula (I) are modulators of the androgen receptor (ar) in a tissue selective manner.
结构式(i)的化合物是组织选择性的雄激素受体(AR)调节剂。
Compounds of structural formula (I) are modulators of the androgen receptor (ar) in a tissue selective manner.
结构式(i)的化合物是组织选择性的雄激素受体(AR)调节剂。
应用推荐